CoViD-19

remdesivir drug

Two-Thirds of Severely Ill Coronavirus Patients Recovered With Remdesivir But Experts Remain Doubtful

Medicine & Technology The Antiviral, Remdesivir from Gilead Sciences, sparks hope as a new study revealed two-thirds of severely ill coronavirus patients improved after the use of the drug. Although the results of the study seem promising, many experts believe that proof of the drug's effectivity is still lacking. To answer important questions, more studies need to be conducted on a wide variety of patients. Click the link above to find out more.
71 72 73 74 75 76 77 78 79 80  

Recommended Stories

Real Time Analytics